LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Anti-tuberculosis medication and the liver: dangers and recommendations in management.

Thompson, N P / Caplin, M E / Hamilton, M I / Gillespie, S H / Clarke, S W / Burroughs, A K / McIntyre, N

The European respiratory journal

1995  Volume 8, Issue 8, Page(s) 1384–1388

Abstract: ... recommendations with regard to monitoring liver function, and what to do when these tests become abnormal, vary ... dysfunction with anti-tuberculosis medications and how might it be prevented? Anti-tuberculosis chemotherapy is ... In the light of three deaths due to liver failure secondary to anti-tuberculosis therapy ...

Abstract In the light of three deaths due to liver failure secondary to anti-tuberculosis therapy at the Royal Free Hospital, we have reviewed the current literature, and asked--How common is liver dysfunction with anti-tuberculosis medications and how might it be prevented? Anti-tuberculosis chemotherapy is associated with abnormalities in liver function tests in 10-25% of patients. Clinical hepatitis develops in about 3%, though estimates vary, and in these patients there is likely to be significant morbidity and mortality. On the basis of reported cases of tuberculosis, 160 patients in England and Wales can be expected to develop drug-induced hepatitis due to anti-tuberculosis therapy each year. There are published guidelines from the British and American Thoracic Societies regarding the choice of drug therapy for tuberculosis. Current recommendations with regard to monitoring liver function, and what to do when these tests become abnormal, vary considerably. We suggest a protocol for using liver function tests to monitor for liver damage, and give recommendations on what action to take when these become abnormal.
MeSH term(s) Antitubercular Agents/administration & dosage ; Antitubercular Agents/adverse effects ; Chemical and Drug Induced Liver Injury/etiology ; Humans ; Liver/drug effects ; Risk Factors
Chemical Substances Antitubercular Agents
Language English
Publishing date 1995-08
Publishing country England
Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
ZDB-ID 639359-7
ISSN 1399-3003 ; 0903-1936
ISSN (online) 1399-3003
ISSN 0903-1936
DOI 10.1183/09031936.95.08081384
Shelf mark
Zs.A 2322: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Zs.MO 292: Show issues
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top